Literature DB >> 10600539

Mutations of the IL-12 receptor beta2 chain gene in atopic subjects.

E Matsui1, H Kaneko, T Fukao, T Teramoto, R Inoue, M Watanabe, K Kasahara, N Kondo.   

Abstract

Interleukin-12(IL-12) promotes cell-mediated Th1 responses and production of IFN-gamma that downregulates IgE production. The signal of IL-12 is transduced through the IL-12 receptor (IL-12R) and Stat4. Twenty-four of 75 atopic individuals with high levels of IgE showed insufficient IFN-gamma production by peripheral blood mononuclear cells (PBMCs) following stimulation with IL-12 but not that with phytohemagglutinin (PHA). Interestingly, 10 of the above 24 subjects were found to be heterozygous for truncated (2496 del 91) or missense (1577 A to G and 2799 A to G) mutations of IL-12R beta2 chain gene (IL-12R beta2). Insufficient phosphorylation of Stat4 was also demonstrated in these 10 individuals. This is the first report showing that reduced IFN-gamma production following IL-12 stimulation is associated with the heterozygous IL-12R beta2 mutations in atopic subjects. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600539     DOI: 10.1006/bbrc.1999.1859

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

Review 2.  IL-35 and Autoimmunity: a Comprehensive Perspective.

Authors:  Jinjung Choi; Patrick S C Leung; Christopher Bowlus; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

3.  Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children.

Authors:  Philip M D Wood; Claire Fieschi; Capucine Picard; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  Eur J Pediatr       Date:  2005-08-23       Impact factor: 3.183

4.  Influence of atopic heredity on IL-4-, IL-12- and IFN-gamma-producing cells in in vitro activated cord blood mononuclear cells.

Authors:  S Gabrielsson; A Söderlund; C Nilsson; G Lilja; M Nordlund; M Troye-Blomberg
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  Association study between interleukin-12 receptor beta1/beta2 genes and type 1 diabetes or asthma in the Japanese population.

Authors:  Wafaa M Bassuny; Kenji Ihara; Junko Kimura; Shigeki Ichikawa; Ryuichi Kuromaru; Kenichi Miyako; Kouichi Kusuhara; Yuka Sasaki; Hitoshi Kohno; Nobuo Matsuura; Sankei Nishima; Toshiro Hara
Journal:  Immunogenetics       Date:  2003-04-26       Impact factor: 2.846

6.  mRNA expression and RNA editing (2451 C-to-U) of IL-12 receptor beta2 in adult atopic patients.

Authors:  Eun Jin Kim; Won Mok Lee; Jung Sook Ha; Nam Hee Ryoo; Dong Suk Jeon; Jae Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

7.  Pharmacogenetics of asthma in children.

Authors:  Naomi Kondo; Eiko Matsui; Akane Nishimura; Hideo Kaneko
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

8.  Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients.

Authors:  Vikas Kumar Verma; Vibha Taneja; Anand Jaiswal; Sangeeta Sharma; Digamber Behera; Vishnubhatla Sreenivas; Shyam Singh Chauhan; Hanumanthappa Krishna Prasad
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

Review 9.  A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12.

Authors:  David J Klinke
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

10.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.